首页> 外文期刊>Mutation Research: International Journal on Mutagenesis, Chromosome Breakage and Related Subjects >A common mechanism of action for the N-glycosylase activity of DNA N-glycosylase/AP lyases from E. coli and T4.
【24h】

A common mechanism of action for the N-glycosylase activity of DNA N-glycosylase/AP lyases from E. coli and T4.

机译:大肠杆菌和T4的DNA N-糖基化酶/ AP裂解酶的N-糖基化酶活性的共同作用机制。

获取原文
获取原文并翻译 | 示例
           

摘要

Duplex oligonucleotides containing the base lesion analogs, O-methylhydroxylamine- and O-benzylhydroxylamine-modified abasic (AP) sites, were substrates for the DNA N-glycosylases endonuclease III, formamidopyrimidine DNA N-glycosylase and T4 endonuclease V. These N-glycosylases are known to have associated AP lyase activities. In contrast, uracil DNA N-glycosylase, a simple N-glycosylase which does not have an associated AP lyase activity, was unable to recognize the modified AP sites. Endonuclease III, formamidopyrimidine DNA N-glycosylase and T4 endonuclease V recognized the base lesion analogs as N-glycosylases generating intermediary AP sites which were subsequently cleaved by the enzyme-associated AP lyase activities. Kinetic measurements showed that O-alkoxyamine-modified AP sites were poorer substrates than the presumed physiological substrates. For endonuclease III, DNA containing O-methylhydroxyl-amine or O-benzylhydroxylamine was recognized at 12 and 9% of the rate of DNA containing thymine glycol, respectively, under subsaturating substrate concentrations (as determined by relative Vmax/K(m)). Similarly, with formamidopyrimidine DNA N-glycosylase and T4 endonuclease V. DNA containing O-methylhydroxylamine or O-benzylhydroxylamine was recognized at 4-9% of the efficiency of DNA containing N7-methyl formamidopyrimidine or pyrimidine cyclobutane dimers, respectively. Based on the known structures of these base lesion analogs and the substrate specificities of the N-glycosylases, a common mechanism of action is proposed for DNA N-glycosylases with an associated AP lyase activity.
机译:包含碱基病变类似物,O-甲基羟胺和O-苄基羟胺修饰的无碱基(AP)位点的双链寡核苷酸是DNA N-糖基化酶核酸内切酶III,甲酰胺基嘧啶DNA N-糖基化酶和T4核酸内切酶V的底物。这些N-糖基化酶是已知具有相关的AP裂解酶活性。相反,尿嘧啶DNA N-糖基化酶,一种不具有相关的AP裂解酶活性的简单N-糖基化酶,无法识别修饰的AP位点。核酸内切酶III,甲酰胺基嘧啶DNA N-糖基化酶和T4核酸内切酶V将碱基病变类似物识别为N-糖基化酶,产生中间AP位点,随后被酶相关的AP裂解酶活性裂解。动力学测量表明,O-烷氧基胺修饰的AP位点比假定的生理底物差。对于核酸内切酶III,在亚饱和底物浓度(由相对Vmax / K(m)确定)下,分别以包含胸腺嘧啶二醇的DN​​A的比率的12%和9%识别出包含O-甲基羟胺或O-苄基羟胺的DNA。类似地,对于甲酰胺基嘧啶DNA,N-糖基化酶和T4核酸内切酶V.含有O-甲基羟胺或O-苄基羟胺的DNA分别被识别为含有N7-甲基甲酰胺基嘧啶或嘧啶环丁烷二聚体的DNA效率的4-9%。基于这些基本病变类似物的已知结构和N-糖基化酶的底物特异性,提出了具有相关AP裂解酶活性的DNA N-糖基化酶的共同作用机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号